Results 121 to 130 of about 6,882 (175)

Drug-induced plasma discolouration mimicking icterus risks inappropriate withholding of critical lactate. [PDF]

Pract Lab Med
Kerr B, Murphy A, Houstoun C, Tan J, Mykytiv V, Costelloe SJ.   +5 more
europepmc   +1 more source

Evolving Paradigms in the Management of Primary Immune Thrombocytopenia in Adults: From Corticosteroids to Targeted Therapies. [PDF]

Mediterr J Hematol Infect Dis
Martino M, Giordano L, Greve MB, Marafioti V, Alati C.   +4 more
europepmc   +1 more source

Flow cytometric analysis of T-cell subsets and platelet surface markers in patients with immune thrombocytopenia: a case-control study. [PDF]

Ann Hematol
Kara M, Aytan P, Gülüm C, Çimen MBY.
europepmc   +1 more source

Evolving Patterns of TPO-RA Use in Children: A Decade of Single-Centre Experience and Narrative Review. [PDF]

Int J Mol Sci
Urbański B, Gaszyńska M, Kasprzycka I, Kowalczyk O, Wegner O, Wojdalska M, Zjawiona M, Młynarski W, Janczar S.   +8 more
europepmc   +1 more source

Exploiting iron metabolism in Ewing sarcoma. [PDF]

Commun Med (Lond)
Hayes CM, Theisen ER.
europepmc   +1 more source

Concentration dependency of an acyl glucuronide metabolite in eltrombopag-induced hepatotoxicity: Role of UGT1A1 genotype. [PDF]

Br J Clin Pharmacol
Oda S, Doki K, Obara N, Suzuki Y, Sakata-Yanagimoto M, Homma M.   +5 more
europepmc   +1 more source

Effect of efgartigimod IV on immature platelet fraction in primary immune thrombocytopenia in the ADVANCE IV trial. [PDF]

Br J Haematol
Al-Samkari H, Matthijssens F, Nishiwaki K, Zaja F, Audia S, Miyakawa Y, Ayguasanosa J, Chimits D, Hultberg A, Ulrichts P.   +9 more
europepmc   +1 more source

Cost-effectiveness of frontline eltrombopag with immunosuppressive therapy for severe aplastic anemia. [PDF]

Blood Red Cells Iron
Ito S, Potnis KC, Ng DQ, Patel KK, Sra M, Shallis RM, Podoltsev NA, Kewan T, Stempel JM, Mendez L, Huntington SF, Stahl M, Zeidan AM, Bewersdorf JP, Goshua G.   +14 more
europepmc   +1 more source

Cyclic Thrombocytopenia Complicated by Thrombosis and Successfully Treated With Rituximab: A Diagnostic and Therapeutic Challenge. [PDF]

J Brown Hosp Med
Nicacio JM, Diniz LFB, Fernandes ALM.
europepmc   +1 more source

MPL receptor dimerization and the thrombopoietin pathway in primary immune thrombocytopenia: from molecular mechanisms to targeted therapies. [PDF]

Front Med (Lausanne)
Wang Y, Liu C, Hu Y, Sun X, Zhang W, Zhu W.   +5 more
europepmc   +1 more source